Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Nov 6, 2020; 8(21): 5104-5115
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5104
Table 2 Univariate and multivariate Cox regression analyses for predicting oncological outcomes in patients treated with radical nephroureterectomy for upper urinary tract urothelial carcinoma
VariableIRFS
CSS
OS
Univariate analysis
Multivariate analysis
Univariate analysis
Multivariate analysis
Univariate analysis
Multivariate analysis
HR
95%CI
P value
HR
95%CI
P value
HR
95%CI
P value
HR
95%CI
P value
HR
95%CI
P value
HR
95%CI
P value
Age < 70 yr vs age ≥ 70 yr0.7990.412-1.5500.507-0.9680.398-2.3530.9431.3400.656-2.7370.421
Male vs female0.5350.273-1.0470.068-0.8200.339-1.9860.6610.6440.315-1.3190.229
BCE methods0.987-0.8260.503
IVBC1Reference--1Reference-1Reference-
EVBC1.0320.474-2.2460.9370.7070.235-2.1280.5370.5870.223-1.5420.280
TUBC0.9540.392-2.3230.9170.8790.276-2.7970.8280.6950.256-1.8840.474
Tumor location0.0420.0420.5640.161
Lower ureter1Reference-1Reference-1Reference-1Reference-
Middle and upper ureter0.4210.177-1.0020.0510.4210.177-1.0020.0510.9300.295-2.9330.9011.1480.451-2.9200.772
Renal pelvis or calyx0.3390.153-0.7500.0080.3390.153-0.7500.0080.5050.160-1.5980.2450.4660.176-1.2300.123
Multiple0.3150.007-1.4160.1320.3150.007-1.4160.1320.4590.053-3.9730.4790.5000.102-2.4620.394
pT ≤ 2 vs pT > 20.5670.273-1.1780.1289.1562.673-31.3580.0008.4392.424-29.3770.0012.9701.417-6.2250.0042.8911.364-6.1280.006
LN (-/x) vs LN (+)0.9010.123-6.5860.91816.7936.328-44.5680.00014.3435.176-39.745< 0.0019.9173.995-24.6210.0009.4733.75-23.926< 0.001
Tumor grade 0.9880.383-2.5470.98025.3670.083-7755.8520.2680.9810.341-2.8260.972
LV (-) vs LV (+)0.6110.146-2.5520.4992.9330.969-8.8810.0572.3850.907-6.2730.078
Urinary cytology 0.9930.478-2.0640.9861.4740.492-4.4190.4881.4460.592-3.5320.418
Intravesical chemotherapy (yes vs no)1.0230.503-2.0810.9500.6060.202-1.8160.3710.8520.380-1.9090.697